Roflumilust in Chronic Rhinosinusitis With Nasal Polyposis.
Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The current study will be a pilot study for a randomized controlled trial conducted on 60
patients recruited from the outpatient clinic of the Otorhinolaryngology Department, Menoufia
Faculty of Medicine after approval of the institutional review board and taking informed
written consent from every patient before participation in the study. The patients of this
study will be randomly and equally distributed among case and control groups to compare the
effect of Roflumilust administration with the effect of systemic and local corticosteroids on
patients with chronic rhinosinusitis with nasal polyposis